Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
10.36
+6.07 (141.49%)
At close: Oct 8, 2025, 4:00 PM EDT
9.70
-0.66 (-6.37%)
After-hours: Oct 8, 2025, 7:12 PM EDT
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $15.98 million as of October 8, 2025. Its market cap has increased by 161.91% in one year.
Market Cap
15.98M
Enterprise Value
10.19M
1-Year Change
161.91%
Ranking
Category
Stock Price
$10.36
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $15.98M, a decrease of -66.51%. That is a compound annual growth rate of -11.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 6.60M | 6.45% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
| Jun 30, 2016 | 47.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.98B |
| Johnson & Johnson | 445.95B |
| AbbVie | 405.14B |
| UnitedHealth Group | 326.77B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 230.66B |